Biotechnology
Earnings: Array BioPharma delivers strong Q2 results, investors cheer
Array BioPharma (ARRY) reported 44% jump in second-quarter revenue to $82.5 million, driven by higher product sales and recognition of…
Earnings preview: HIV to drive topline growth for Gilead Sciences in Q4
Biotechnology company Gilead Sciences (GILD) is scheduled to report fourth-quarter earnings results after the closing bell on Monday, February 4.…
Cambrex Corp. completes acquisition of Avista Pharma solutions
Life sciences company Cambrex Corp. (CBM) Wednesday completed its previously announced acquisition of Avista Pharma Solutions, a biotech firm engaged…
Avid Bioservices Q2 loss narrows despite lower revenues; reaffirms outlook
Avid Bioservices (CDMO) reported a narrower net loss for the second quarter of 2019, helped by a sharp decline in…
Earnings Preview: Q2 results may set the tone for Avid Bioservices’ recovery
Avid Bioservices (CDMO), a contract manufacturer in the biotechnology industry, is scheduled to release its second-quarter financial results Monday after…